Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,860
Closed -$367K 835
2026
Q1
$367K Buy
+4,860
New +$365K 0.01% 415
2025
Q4
Sell
-5,184
Closed -$350K 654
2025
Q3
$350K Buy
5,184
+356
+7% +$23.6K 0.01% 300
2025
Q2
$315K Buy
4,828
+284
+6% +$17K 0.01% 291
2025
Q1
$281K Buy
+4,544
New +$301K 0.01% 272

Other funds holding HOLX

Aristeia Capital's HOLX Position: Q2 2026 in Review

Aristeia Capital sold out of Hologic (HOLX) in Q2 2026, closing a stake of 4,860 shares — an estimated $367K sold.

Aristeia Capital first reported a position in HOLX in Q1 2025 and held it in 4 quarters. The position peaked at $367K in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Aristeia Capital reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Aristeia Capital sold 4,860 Hologic shares in Q2 2026, an estimated $367K.
  • Aristeia Capital first reported a position in Hologic in Q1 2025 and held it in 4 quarters.
  • Aristeia Capital's Hologic position peaked at $367K in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Aristeia Capital's 13F filing for Q2 2026, filed 14 Aug 2026.